A carregar...
Upregulation of the EMT marker vimentin is associated with poor clinical outcome in acute myeloid leukemia
BACKGROUND: Vimentin (VIM) is a type III intermediate filament that maintains cell integrity, and is involved in cell migration, motility and adhesion. When overexpressed in solid cancers, vimentin drives epithelial to mesenchymal transition (EMT) and ultimately, metastasis. The effects of its overe...
Na minha lista:
| Publicado no: | J Transl Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6009962/ https://ncbi.nlm.nih.gov/pubmed/29925392 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-018-1539-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|